Open original FDA record ↗Recall record
- FDA identifier
- Z-2273-2025
- Company in FDA record
- Boston Scientific Corporation
- FDA classification date
- Aug 8, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Certain batches are being removed due to an increase in complaints received in which physicians encountered greater than anticipated resistance while attempting to withdraw the stent delivery system (SDS) from the guidewire or embolic protection device (EPD) after successful stent deployment. The most serious potential adverse health consequence is stroke. Other risks include delay to procedure, vessel injury, vessel spasm, or stent disruption/damage necessitating additional intervention.
Source facts
- Action
- On July 7, 2025, the firm sent "Urgent Medical Device Removal" customer notifications to all affected accounts either via FedEx Overnight Delivery or in person delivery by sales representatives. The letter provided customers with information about identifying the product and instructions for product segregation and return. 1. Further distribution or use of any remaining devices (Attachment 1) affected by this removal should cease immediately. Do NOT use affected devices and remove those devices from your facility s inventory. Segregate the units in a secure place until they can be returned to Boston Scientific. 2. Immediately post this information in a visible location near the affected devices to ensure it is readily accessible to all handlers and users of the device. 3. Forward this notice to any healthcare professional from your organization and to any facilities where affected devices have been transferred, including hospitals or sites within your network. If you are a distributor, this notice must be forwarded to your customers to ensure notification of this device removal is carried out to the end-user level. 4. Complete and return the enclosed Reply Verification Tracking Form via email: BSCFieldActionCenter@bsci.com or fax: BSC Field Action Center 1-763-415-7708. 5. Return affected devices to Boston Scientific. If you have any questions, call the Quality Systems Manager II at 763-494-1700.
- Initiated
- 2025-07-07
- Root cause
- Process change control
- Distribution
- Domestic US Nationwide distribution including Puerto Rico. International distribution worldwide.
- Recall number
- Z-2273-2025
- Recall status
- Open, Classified
- CDRH record ID
- 214951
- FDA classified
- 2025-08-08
- Recall event number
- 97243